Theracell And AlloSource Announce Second Patent For Bone Fiber Technology
Demineralized Bone Fiber (DBF™) patent to expand TheraCell’s osteobiologic patent portfolio Northridge, Cali. and Centennial, Colo. — March 9, 2017 — TheraCell, a regenerative medicine company, today announced it was awarded a second patent for its demineralized bone fiber (DBF™) technology by the…
March 9, 2017Press ReleasesAlloFuse,TheraCell,AlloSource,Demineralized Bone Fiber (DBF™)
TheraCell And AlloSource Announce Issuance Of Patent For Bone Fiber Technology
Northridge, Calif. and Centennial, Colo. — Oct. 25, 2016 — TheraCell, a regenerative medicine company, today announced that the United States Patent and Trademark Office (USPTO) will issue TheraCell a patent for its demineralized bone fiber (DBF™) technology. The addition of this patent expands…
October 25, 2016Press ReleasesAlloFuse,TheraCell,AlloSource,Demineralized Bone Fiber (DBF™)
AlloSource Announces Two Innovative Bone Fiber AlloGrafts
AlloFuse® Cortical Fibers and AlloFuse® Fiber Boat will expand the company’s osteobiologic bone graft portfolio Centennial, Colo. — June 13, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and…
June 13, 2016Press ReleasesTheraCell,AlloFuse Fiber Boat,AlloSource,AlloFuse Cortical Fibers,bone graft